One significance of the patent filing is that the Company is now able to speak more freely about this new test. The next catalyst I'm looking forward to is updates related to this; i.e., Dr. Rodgers being in touch with his colleagues at the Battelle, the CDC and elsewhere.

Given how critical rapid, sensitive, accurate and point of care testing is necessary toward opening up the economy, I have to believe a licensing deal will happen much faster than typical.